3i Infotech Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 7:26 pm

Quick Insight

3i Infotech Ltd, a player in the IT consulting and software industry, currently trades at a price of 22.4 with a market capitalization of 381 Cr. The company's P/E stands at 8.03, indicating a reasonable valuation, while ROE and ROCE are at 8.45% and 5.13%, respectively, reflecting moderate profitability. However, the negative OPM of -2.03% raises concerns about operational efficiency. With Promoters' stake not available and significant ownership by the public (90.25%), the company's governance structure may warrant further scrutiny. The high level of borrowings at ₹64Cr and negative ICR of -0.99x indicate potential financial risks. In conclusion, investors should carefully evaluate operational performance and financial health before considering an investment in 3i Infotech Ltd.

Competitors of 3i Infotech Ltd

All Competitor Stocks of 3i Infotech Ltd

Quarterly Result

Last Updated: August 2, 2025, 1:05 am

Below is a detailed analysis of the quarterly data for 3i Infotech Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 170.55 Cr.. The value appears to be declining and may need further review. It has decreased from 187.00 Cr. (Mar 2025) to 170.55 Cr., marking a decrease of 16.45 Cr..
• For Expenses, as of Jun 2025, the value is 174.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 178.65 Cr. (Mar 2025) to 174.01 Cr., marking a decrease of 4.64 Cr..
• For Operating Profit, as of Jun 2025, the value is -3.46 Cr.. The value appears to be declining and may need further review. It has decreased from 8.35 Cr. (Mar 2025) to -3.46 Cr., marking a decrease of 11.81 Cr..
• For OPM %, as of Jun 2025, the value is -2.03%. The value appears to be declining and may need further review. It has decreased from 4.47% (Mar 2025) to -2.03%, marking a decrease of 6.50%.
• For Other Income, as of Jun 2025, the value is 21.53 Cr.. The value appears strong and on an upward trend. It has increased from 5.83 Cr. (Mar 2025) to 21.53 Cr., marking an increase of 15.70 Cr..
• For Interest, as of Jun 2025, the value is 1.35 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.54 Cr. (Mar 2025) to 1.35 Cr., marking a decrease of 0.19 Cr..
• For Depreciation, as of Jun 2025, the value is 4.62 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.35 Cr. (Mar 2025) to 4.62 Cr., marking a decrease of 1.73 Cr..
• For Profit before tax, as of Jun 2025, the value is 12.10 Cr.. The value appears strong and on an upward trend. It has increased from 6.29 Cr. (Mar 2025) to 12.10 Cr., marking an increase of 5.81 Cr..
• For Tax %, as of Jun 2025, the value is 37.60%. The value appears to be increasing, which may not be favorable. It has increased from -327.66% (Mar 2025) to 37.60%, marking an increase of 365.26%.
• For Net Profit, as of Jun 2025, the value is 7.55 Cr.. The value appears to be declining and may need further review. It has decreased from 26.90 Cr. (Mar 2025) to 7.55 Cr., marking a decrease of 19.35 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.45. The value appears to be declining and may need further review. It has decreased from 1.59 (Mar 2025) to 0.45, marking a decrease of 1.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 7:26 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:35 pm

Below is a detailed analysis of the balance sheet data for 3i Infotech Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 170.00 Cr.. The value appears strong and on an upward trend. It has increased from 169.00 Cr. (Mar 2024) to 170.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 137.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Mar 2024) to 137.00 Cr., marking an increase of 13.00 Cr..
• For Borrowings, as of Mar 2025, the value is 64.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 84.00 Cr. (Mar 2024) to 64.00 Cr., marking a decrease of 20.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 202.00 Cr.. The value appears to be improving (decreasing). It has decreased from 286.00 Cr. (Mar 2024) to 202.00 Cr., marking a decrease of 84.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 573.00 Cr.. The value appears to be improving (decreasing). It has decreased from 664.00 Cr. (Mar 2024) to 573.00 Cr., marking a decrease of 91.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 226.00 Cr.. The value appears to be declining and may need further review. It has decreased from 245.00 Cr. (Mar 2024) to 226.00 Cr., marking a decrease of 19.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 6.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 344.00 Cr.. The value appears to be declining and may need further review. It has decreased from 411.00 Cr. (Mar 2024) to 344.00 Cr., marking a decrease of 67.00 Cr..
• For Total Assets, as of Mar 2025, the value is 573.00 Cr.. The value appears to be declining and may need further review. It has decreased from 664.00 Cr. (Mar 2024) to 573.00 Cr., marking a decrease of 91.00 Cr..

Notably, the Reserves (137.00 Cr.) exceed the Borrowings (64.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for 3i Infotech Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is -17.69. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 23) to -17.69, marking a decrease of 17.77.
• For Diluted EPS (Rs.), as of Mar 24, the value is -17.69. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 23) to -17.69, marking a decrease of 17.77.
• For Cash EPS (Rs.), as of Mar 24, the value is -16.02. This value is below the healthy minimum of 3. It has decreased from 1.43 (Mar 23) to -16.02, marking a decrease of 17.45.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 17.34. It has decreased from 38.16 (Mar 23) to 17.34, marking a decrease of 20.82.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 17.34. It has decreased from 38.16 (Mar 23) to 17.34, marking a decrease of 20.82.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 48.09. It has increased from 43.28 (Mar 23) to 48.09, marking an increase of 4.81.
• For PBDIT / Share (Rs.), as of Mar 24, the value is -0.59. This value is below the healthy minimum of 2. It has decreased from 2.46 (Mar 23) to -0.59, marking a decrease of 3.05.
• For PBIT / Share (Rs.), as of Mar 24, the value is -2.20. This value is below the healthy minimum of 0. It has decreased from 1.11 (Mar 23) to -2.20, marking a decrease of 3.31.
• For PBT / Share (Rs.), as of Mar 24, the value is -16.78. This value is below the healthy minimum of 0. It has decreased from 0.25 (Mar 23) to -16.78, marking a decrease of 17.03.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -17.63. This value is below the healthy minimum of 2. It has decreased from 0.08 (Mar 23) to -17.63, marking a decrease of 17.71.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -17.63. This value is below the healthy minimum of 2. It has decreased from 0.08 (Mar 23) to -17.63, marking a decrease of 17.71.
• For PBDIT Margin (%), as of Mar 24, the value is -1.23. This value is below the healthy minimum of 10. It has decreased from 5.68 (Mar 23) to -1.23, marking a decrease of 6.91.
• For PBIT Margin (%), as of Mar 24, the value is -4.57. This value is below the healthy minimum of 10. It has decreased from 2.56 (Mar 23) to -4.57, marking a decrease of 7.13.
• For PBT Margin (%), as of Mar 24, the value is -34.88. This value is below the healthy minimum of 10. It has decreased from 0.60 (Mar 23) to -34.88, marking a decrease of 35.48.
• For Net Profit Margin (%), as of Mar 24, the value is -36.64. This value is below the healthy minimum of 5. It has decreased from 0.18 (Mar 23) to -36.64, marking a decrease of 36.82.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is -36.64. This value is below the healthy minimum of 8. It has decreased from 0.18 (Mar 23) to -36.64, marking a decrease of 36.82.
• For Return on Networth / Equity (%), as of Mar 24, the value is -101.64. This value is below the healthy minimum of 15. It has decreased from 0.21 (Mar 23) to -101.64, marking a decrease of 101.85.
• For Return on Capital Employeed (%), as of Mar 24, the value is -10.77. This value is below the healthy minimum of 10. It has decreased from 2.63 (Mar 23) to -10.77, marking a decrease of 13.40.
• For Return On Assets (%), as of Mar 24, the value is -44.92. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 23) to -44.92, marking a decrease of 45.06.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.14. This value is within the healthy range. It has increased from 0.05 (Mar 23) to 0.14, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.99. It has increased from 0.75 (Mar 23) to 0.99, marking an increase of 0.24.
• For Current Ratio (X), as of Mar 24, the value is 1.05. This value is below the healthy minimum of 1.5. It has decreased from 1.32 (Mar 23) to 1.05, marking a decrease of 0.27.
• For Quick Ratio (X), as of Mar 24, the value is 1.05. This value is within the healthy range. It has decreased from 1.32 (Mar 23) to 1.05, marking a decrease of 0.27.
• For Interest Coverage Ratio (X), as of Mar 24, the value is -0.99. This value is below the healthy minimum of 3. It has decreased from 4.46 (Mar 23) to -0.99, marking a decrease of 5.45.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -5.10. This value is below the healthy minimum of 3. It has decreased from 1.69 (Mar 23) to -5.10, marking a decrease of 6.79.
• For Enterprise Value (Cr.), as of Mar 24, the value is 655.29. It has increased from 433.98 (Mar 23) to 655.29, marking an increase of 221.31.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.80. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 23) to 0.80, marking an increase of 0.21.
• For EV / EBITDA (X), as of Mar 24, the value is -65.01. This value is below the healthy minimum of 5. It has decreased from 10.46 (Mar 23) to -65.01, marking a decrease of 75.47.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.82. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 23) to 0.82, marking an increase of 0.19.
• For Price / BV (X), as of Mar 24, the value is 2.28. This value is within the healthy range. It has increased from 0.71 (Mar 23) to 2.28, marking an increase of 1.57.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.82. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 23) to 0.82, marking an increase of 0.19.
• For EarningsYield, as of Mar 24, the value is -0.44. This value is below the healthy minimum of 5. It has decreased from 0.00 (Mar 23) to -0.44, marking a decrease of 0.44.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness